The Cross Cancer Institute (Edmonton, AB) wanted to optimize chemotherapy treatments to help block cancerous proteins from proliferating throughout a patient’s system. Specifically, they are looking to provide the best possible combination of chemotherapy drugs to block cancers from proliferating – by knowing the optimal combinations, we can reduce the amount of drugs the patient needs to take, which in turn should reduce the side effects that they experience.
Goals:
- Reducing the dosage of chemotherapy drugs needed to block cancers from proliferating in the patient’s system.
- Determining the optimal drug combinations for treating various types of cancers.
